Arylhydrocarbonhydroxylase Inducibility and Smoking Habits in Patients with Laryngeal Carcinomas

References

• Gregoriades G. Cancer of the endolarynx (analysis of 415 cases). J Laryng Otol 1974; 88: 749–57
   PubMedGoogle Scholar
• Wallen V. Survey of the background characteristics of 2000 laryngectomees: A preliminary report. Proceedings of the 23rd annual meeting, International Association of Laryngectomees. Philadelphia 1974; 8
   Google Scholar
• American Cancer Society. 75 cancer facts and figures. American Cancer Society, New York 1974
   Google Scholar
• Tokuhata G K. Familial factors in human lung cancer and smoking. Am J Popul Hlth 1964; 54: 24–9
   PubMed Web of Science ®Google Scholar
• Miller J A. Carcinogenesis by chemicals: An overview. Cancer Res 1970; 30: 559–76
   PubMed Web of Science ®Google Scholar
• Gelboin H V, Huberman E, Sachs L. Enzymatic hydroxylation of benzopyrene and its relation to cytotoxicity. Proc Natl Acad Sci USA 1969; 64: 1188–94
   PubMed Web of Science ®Google Scholar
• Huberman E, Aspiras L, Heidelberger C, et al. Mutagenicity to mammalian cells of epoxides and other derivatives of polycyclic hydrocarbons. Proc Natl Acad Sci USA 1971; 68: 3195–9
   PubMed Web of Science ®Google Scholar
• Selkirk J K, Huberman E, Heidelberger C. An epoxide is an intermediate in the microsomal metabolism of the chemical carcinogen, dibenz(a, h) anthracene. Biochem Biophys Res Commun 1971; 43: 1010–6
   PubMed Web of Science ®Google Scholar
• Grover P L, Sims P. K-region epoxides of polycyclic hydrocarbons. Reactions with nucleic acids and polyribonucleotides. Biochem Pharmacol 1973; 22: 661–6
   PubMed Web of Science ®Google Scholar
• Rogan E G, Cavalieri E. 3-methylcholanthrene-inducible binding of aromatic hydrocarbons to DNA in purified rat liver nuclei. Biochem Biophys Res Commun 1974; 58: 1119–26
   PubMed Web of Science ®Google Scholar
• Love D L. The chemical mechanisms of carcinogenesis—a hypothesis. 1974; 17, Naval Ordnance Lab Techn Report No. 74–197
   Google Scholar
• Brookes P. Covalent interaction of carcinogens with DNA. Life Sci 1975; 16: 331–44
   PubMedGoogle Scholar
• Conney A H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 1967; 19: 317–66
   PubMed Web of Science ®Google Scholar
• Nebert D W, Gelboin H V. Substrate-inducible microsomal arylhydrocarbon hydroxylase in mammalian cell culture. II. Cellular responses during enzyme induction. J Biol Chem 1968; 243: 6250–61
   PubMed Web of Science ®Google Scholar
• Nebert D W, Sausserman L L, Bates R R. Effect of 17-β-estradiol and testosterone on aryl hydrocarbon hydroxylase activity in mouse tissues in vivo and in cell culture. Int J Cancer 1970; 6: 470–80
   PubMedGoogle Scholar
• Gurtoo H L, Bejba N, Minovada J. Properties, inducibility and an improved method of analysis of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Cancer Res 1975; 35: 1235–43
   PubMed Web of Science ®Google Scholar
• Nebert D W, Goujon F M, Gielen J E. Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse. Nature 1972; 236: 107–10
   Google Scholar
• Kellerman G, Luyten-Kellerman M, Shaw C R. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am J Human Genet 1973; 25: 327–331
   PubMed Web of Science ®Google Scholar
• Bürki K, Liebelt A G, Bresnick E. Induction of aryl hydrocarbon hydroxylase in mouse tissue from a high and low cancer strain and their F1 hybrids. J Natl Cancer Inst 1973; 50: 369–80
   PubMedGoogle Scholar
• Kouri R E, Ratrie H, Whitmire C E. Evidence for a genetic relationship between susceptibility to 3-methylcholanthrene-induced subcutaneous tumours and inducibility of aryl hydrocarbon hydroxylase. J Natl Cancer Inst 1973; 51: 197–200
   PubMedGoogle Scholar
• Kinoshita N, Gelboin H V. The role of aryl hydrocarbon hydroxylase in 7,12-dimethylbenz(a)anthracene skin tumorigenesis: On the mechamism of 7,8-benzoflavone inhibition of tumorigenesis. Cancer Res 1972; 32: 1329–39
   PubMed Web of Science ®Google Scholar
• Coombs M, Bhatt T S, Vose C W. The relationship between metabolism, DNA binding and carcinogenicity of 15,16-dihydro-11methylcyclopenta(a)phenanthren-17-one in the presence of a microsomal enzyme inhibitor. Cancer Res 1975; 35: 305–9
   PubMedGoogle Scholar
• Levin W, Wood A W, Yagi H, et al. Carcinogenicity of benzo(a)pyrene 4,5-, 7,8- and 9,10-oxides on mouse skin. Proc Natl Acad Sci USA 1976; 73: 243–7
   PubMed Web of Science ®Google Scholar
• Kellerman G, Shaw C R, Luyten-Kellerman M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N Eng J Med 1973; 289: 934–7
   PubMed Web of Science ®Google Scholar
• Gelboin H V. Editorial retrospectives. Carcinogens, drugs, and cytochromes P-450. N Engl J Med 1983; 309: 105–7
   PubMed Web of Science ®Google Scholar
• Bøyum A. Separation of leukocytes from blood and bone marrow with special reference to factors which influence and modify sedimentation properties of hematopoietic cells. Scand J Clin Lab Invest 1968, Suppl. 97: 1–109
   PubMedGoogle Scholar
• Thorsby E, Bratlie A. rapid method for preparation of pure lymphocyte suspensions. Histocompatibility testing, P I Terasaki. Munksgaard, Copenhagen 1970
   Google Scholar
• Löfroth G, Natarajan A T. Aryl hydrocarbon hydroxylase in lymphocytes. A means of finding individuals with high susceptibility to bronchogenic carcinoma?. Läkartidn 1975; 72: 593–4
   PubMedGoogle Scholar
• Oesch F, Daly J. Conversion of naphthalene to trans-naphthalene dihydrodiol: evidence for the presence of a coupled aryl monoxygenase epoxide hydrase system in hepatic microsomes. Biochem Biophys Res Commun 1972; 46: 1713–20
   PubMed Web of Science ®Google Scholar
• Kellerman G, Luyten-Kellerman M, Shaw C R. Presence and induction of epoxide hydrase in cultured human leukocytes. Biochem Biophys Res Commun 1973; 52: 712–6, A complete list of references can be obtained on request from the authors
   PubMedGoogle Scholar